Publications by authors named "Thomas Caffrey"

Are you Thomas Caffrey?   Register this Author

Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors.
Cancer Immunol Immunother 2018 Mar 4;67(3):445-457. Epub 2017 Dec 4.
The Eppley Institute for Cancer and Allied Diseases, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, NE, 68198-6805, USA.

Effect of MUC1/β-catenin interaction on the tumorigenic capacity of pancreatic CD133 cells.
Oncol Lett 2016 Sep 20;12(3):1811-1817. Epub 2016 Jul 20.
Institute of Research and Innovation in Health, University of Porto, Porto 4200-135, Portugal; Institute of Molecular Pathology and Immunology of the University of Porto, Porto 4200-135, Portugal; Faculty of Medicine of the University of Porto, Porto 4200-319, Portugal.

MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer.
Proc Natl Acad Sci U S A 2012 Aug 6;109(34):13787-92. Epub 2012 Aug 6.
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.
Clin Cancer Res 2011 Oct 8;17(19):6140-50. Epub 2011 Aug 8.
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska 68198, USA.

Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1).
Cancer Immunol Immunother 2004 Dec;53(12):1068-84
Eppley Institute for Research in Cancer and Allied Diseases, Department of Pathology and Microbiology, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, NE 68198-6805, USA.

Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line.
Cancer Res 2003 Aug;63(16):5011-20
Eppley Institute for Research in Cancer and Allied Diseases, and the Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198-6805, USA.

OF